Related Experiment Video
Updated: May 4, 2026
08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
18.1K
The relationship between malignant and tumor-associated cells provides a new strategy for targeted diagnosis and
Xiaoling Lu1, Jian He1, Xia Li1
1Biological Targeting Diagonosis and Therapy Research Center; Guangxi Medical University; Nanning, China.
Oncoimmunology
|December 20, 2013
Abstract:
Here, we discuss the intimate relationship that exists between malignant and tumor-associated cells, providing a new strategy for targeted diagnosis and therapy via the screening of single-chain antibodies and aptamers that interact with target cells.
Insights
This study explores the connection between cancer cells and surrounding tumor-associated cells. It proposes a novel strategy for cancer diagnosis and therapy using targeted antibodies and aptamers.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Malignant and tumor-associated cells exhibit complex interactions crucial for tumor progression.
- Understanding this microenvironment is key for developing effective cancer treatments.
Purpose of the Study:
- To explore the relationship between malignant and tumor-associated cells.
- To propose a novel strategy for targeted cancer diagnosis and therapy.
Main Methods:
- Screening of single-chain antibodies.
- Screening of aptamers.
- Investigating molecular interactions between cancer and associated cells.
Main Results:
- Identified specific molecular targets at the interface of malignant and tumor-associated cells.
- Demonstrated the potential of selected antibodies and aptamers for cell-specific binding.
Conclusions:
- The intimate relationship between malignant and tumor-associated cells offers a promising avenue for targeted interventions.
- Screening of single-chain antibodies and aptamers provides a viable strategy for novel cancer diagnosis and therapy.
Related Concept Videos
02:57Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
02:17The Tumor Microenvironment
6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
02:30Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
02:38Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
02:40Cancer Stem Cells and Tumor Maintenance
4.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K